
Ophthalmologist

No OPD information available
Age-Related Macular Degeneration (ARMD)
Late-Onset Retinal Degeneration
Diabetic Macular Edema (DME)
Diabetic Retinopathy
Vitrectomy
Chemosis
Episcleritis
Ganglion Cyst
Geographic Atrophy
Glaucoma
Mesenteric Venous Thrombosis
Ocular Hypertension (OHT)
Punctate Inner Choroidopathy
Retinal Detachment
Retinal Vein Occlusion
Scleritis
Andreas S. Ebneter is a male healthcare provider who helps people with eye problems like Age-Related Macular Degeneration, Diabetic Retinopathy, and Glaucoma. He also does surgeries like Vitrectomy and treats conditions like Retinal Detachment and Scleritis.
He is skilled at treating eye diseases and uses special techniques to help patients see better. Patients trust him because he listens to their concerns and explains things clearly. He is kind and caring, which makes people feel comfortable during their appointments.
Andreas S. Ebneter stays updated with the latest medical knowledge by reading research papers and attending conferences. This helps him provide the best care for his patients. He also works closely with other medical professionals to share information and improve patient outcomes.
His work has had a positive impact on many patients' lives by improving their vision and overall eye health. He has published research articles and conducted clinical trials to advance the field of eye care. One of his notable publications is about workplace-based assessments in palliative medicine.
In a clinical trial called "Evaluation of Retinal Structure With High Resolution OCT," Andreas S. Ebneter studied how to better understand eye structures to improve treatments. This trial has been completed and may lead to new ways to help people with eye conditions.
Overall, Andreas S. Ebneter is a dedicated healthcare provider who uses his skills and knowledge to help patients with eye problems. He is respected by his colleagues and trusted by his patients for his expertise and compassionate care.
Enrollment Status: Completed
Published: November 29, 2023
Intervention Type: Other
Study Drug:
Study Phase:
